As diabetes drugs continue to evolve, clinicians must stay informed about emerging therapies, expanded indications, and safety considerations to optimize patient outcomes
Long-term consistency, rather than short-term use, is key for sustained benefits
Compounded GLP-1 Options: Found Health also describes offering compounded semaglutide - both injectable and oral dissolvable tablet formulations - for eligible patients
Implementing preventive strategies such as a balanced diet, lifestyle modifications, and seeking medical interventions can help mitigate hair loss concerns associated with GLP-1 use
Key Milestones at the 12 mg Dose Key Observations from Phase 2 Slow start during escalation (weeks 0-12)
A new double agonist, tirzepatide, marketed as Mounjaro, mimics two, theoretically doubling the strength of the weight-loss effect